Nanomedicines against Chagas disease: a critical review

Scholarly Works

• Freire, V. L. P.; Alves-Silva, M. F.; Oliveira, J. W. d. F.; Fernandes-Pedrosa, M. d. F.; Cornélio, A. M.; de Souza-Silva, M.; Medeiros, T. S.; Junior, A. A. d. S. Phytol-loaded soybean oil nanoemulsion as a promising alternative against Leishmania amazonensis. Beilstein journal of nanotechnology 2025, 16, 1826–1836. doi:10.3762/bjnano.16.126
• da Silva, J. M. F.; Silva, D. M. E.; de Moraes, J.; Tavares, G. D.; da Silva Filho, A. A. Nanotechnology based approaches to the treatment of schistosomiasis: current status and future perspectives. Nanomedicine (London, England) 2025, 1–21. doi:10.1080/17435889.2025.2571018
• García, M.; Magi, M. S.; García, M. C. Harnessing Phytonanotechnology to Tackle Neglected Parasitic Diseases: Focus on Chagas Disease and Malaria. Pharmaceutics 2025, 17, 1043. doi:10.3390/pharmaceutics17081043
• Vermelho, A. B.; Mansoldo, F. R. P.; Cardoso, V. S.; Sette, K. M.; Supuran, C. T.; Rodrigues, I. A. Trypanosoma cruzi and Leishmania spp. CAs. The Enzymes 2025, 57, 129–182. doi:10.1016/bs.enz.2025.05.003
• Santana, E. S. d.; Moraes, M. S. B. d.; Conceição, D. C. d. O.; Oliveira, M. R. d.; Brito, M. E. d. N.; Pereira, V. C. J.; Freitas, D. A. N. d. P.; Silva, Á. D. G. d. B.; Beltrão, F. M. Nanopartículas na otimização da liberação e atividade tripanocida do benznidazol: avanços no design e estratégias terapêuticas. Cuadernos de Educación y Desarrollo 2025, 17, e7648. doi:10.55905/cuadv17n2-124
• Medeiros, T. S.; Bezerra de Lima, L. E.; Alves-Pereira, E. L.; Alves-Silva, M. F.; Dourado, D.; Fernandes-Pedrosa, M. d. F.; Figueiredo, R. C. B. Q. d.; da Silva-Junior, A. A. Cationic and anionic PLGA-cholesterol hybrid nanoparticles as promising platforms to enhance the trypanocidal efficacy of benznidazole and drug delivery in Trypanosoma cruzi-infected cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025, 183, 117782. doi:10.1016/j.biopha.2024.117782
• Ramezani, H.; Sazegar, H.; Rouhi, L. Chitosan-casein as novel drug delivery system for transferring Phyllanthus emblica to inhibit Pseudomonas aeruginosa. BMC biotechnology 2024, 24, 101. doi:10.1186/s12896-024-00907-9
• Perumalsami, D.; Sabapathi, N.; Frank, T. J.; Ganesan, A.; Rengarajan, J. Collagen Nanofiber-Mediated Encapsulation of Gefitinib for Lung Cancer Treatment. BioNanoScience 2024, 15. doi:10.1007/s12668-024-01646-z
• Jacob, J.; Sharma, V. M.; Valsaraj, T. V.; Sudeep, H. V.; Thomas, J.; Kodimule, S. Development, structural characterization, in vitro release and oral bioavailability studies of novel surface-modified natural Fiber Interlaced Liposomal Vitamin C. New Journal of Chemistry 2024, 48, 18957–18966. doi:10.1039/d4nj03773a
• Soto-Sánchez, J.; Garza-Treviño, G. Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases. Pharmaceutics 2024, 16, 1239. doi:10.3390/pharmaceutics16101239
• Taio, F.; Converti, A.; Lima, Á. A. N. d. Cyclodextrin Complexes for the Treatment of Chagas Disease: A Literature Review. International journal of molecular sciences 2024, 25, 9511. doi:10.3390/ijms25179511
• Magi, M. S.; Lopez-Vidal, L.; García, M. C.; Stempin, C. C.; Marin, C.; Maletto, B.; Palma, S. D.; Real, J. P.; Jimenez-Kairuz, A. F. Organic solvent-free benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease. Therapeutic delivery 2024, 15, 699–716. doi:10.1080/20415990.2024.2380244
• Zheng, W.; Huang, Y.; Wu, Q.; Cheng, P.; Song, Y.; Wang, B.; Huang, Q.; Hu, S. Poly(lactic acid hydroxyacetic acid)-poly(ethylene glycol)-modified ginsenoside Rg3 nanomedicine enhances anti-tumor effect in hepatocellular carcinoma. Drug development and industrial pharmacy 2024, 50, 763–775. doi:10.1080/03639045.2024.2402769
• Magi, M. S.; Lopez-Vidal, L.; Rega, P.; Ibarra, M.; Palma, S. D.; Jimenez Kairuz, A.; Real, J. P. 3D printed benznidazole tablets based on an interpolyelectrolyte complex by melting solidification printing process (MESO-PP): An innovative strategy for personalized treatment of Chagas disease. International journal of pharmaceutics 2024, 662, 124476. doi:10.1016/j.ijpharm.2024.124476
• Romero, E. L.; Van Bocxlaer, K.; Formiga, F. R. When nanomedicines meet tropical diseases. Beilstein journal of nanotechnology 2024, 15, 830–832. doi:10.3762/bjnano.15.69

Explore citations to this article at